Money Matters - Simplified

Industry

Is Cliffs Natural Resources' Management Creating Value?

 Warren Buffett's partner, Charlie Munger, once said, "I think I've been in the top 5% of my age cohort all my life in understanding the power of incentives, and all my life I've underestimated it. And never a year passes but I get some surprise that pushes my limit a little farther."

 

Is Edwards Lifesciences Good Enough for You?

 Margins matter. The more Edwards Lifesciences (NYSE: EW) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market.  That's why I check on my holdings' margins at least once a quarter. I'm looking for the absolute numbers, comparisons to sector peers and competitors, and any trend that may tell me how strong Edwards Lifesciences's competitive position could be.

 

Is U.S. Steel's Management Creating Value?

 Warren Buffett's partner, Charlie Munger, once said, "I think I've been in the top 5% of my age cohort all my life in understanding the power of incentives, and all my life I've underestimated it. And never a year passes but I get some surprise that pushes my limit a little farther."

 

This Week’s Rising Star Buy Recommendations

 Peter Lynch famously said that, "In this business if you're good, you're right six times out of 10." So far, our Rising Star picks are exceeding Lynch's rule-of-thumb guideline, though it's still far too early to make a meaningful assessment of our performance. With two of our picks, Cirrus Logic (Nasdaq:CRUS) and ION Geophysical (NYSE: IO), beating the market by more than 20 percentage points at the moment, however, we are optimistic about the future performance of our recommendations. This week, the Rising Stars made four additional buys, which we've summarized briefly below:

 

5-Star Stocks Poised to Pop: Continucare

 Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, outpatient health-care specialist Continucare(NYSE: CNU) has earned a coveted five-star ranking.

 

Is IGT's Stock Expensive by the Numbers?

 Numbers can lie -- but they're the best first step in determining whether a stock is a buy. In this series, we use some carefully chosen metrics to size up a stock's true value based on the following clues:

 

It's Too Late, MySpace

 News Corp.'s (NYSE: NWS) MySpace is trying to do what Friendster, Tribe.net, Bebo, and any social network that squandered its 15 minutes has failed to do. In trying to regain relevance, MySpace is hoping that last month's website makeover will bear fruit in the coming weeks.

 

4-Star Stocks Poised to Pop: STEC

 

Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, memory module and solid-state storage device (SSD) specialist STEC (Nasdaq: STEC) has earned a respected four-star ranking.




4-Star Stocks Poised to Pop: Kimberly-Clark

 Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, consumer-goods giant Kimberly-Clark (NYSE:KMB) earned a respected four-star ranking.

 

4-Star Stocks Poised to Pop: NeuStar

 Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, communications company NeuStar (NYSE: NSR)has earned a respected four-star ranking.